We are live on ! Find out more
OM icon

Outset Medical
OM

78 hedge funds and large institutions have $17.6M invested in Outset Medical in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 36 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more call options, than puts

Call options by funds: $57K | Put options by funds: $56K

2.93% less ownership

Funds ownership: 6.26% → 3.33% (-2.9%)

36% less funds holding

Funds holding: 122 → 78 (-44)

56% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 36

88% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 50

91% less capital invested

Capital invested by funds: $187M → $17.6M (-$169M)

Holders
78
Holders Change
-44
Holders Change %
-36.07%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
16
Reduced
36
Closed
50
Calls
$57K
Puts
$56K
Net Calls
+$1K
Net Calls Change
-$361K

Top Buyers

1
GCP
GSA Capital Partners
United Kingdom
+$1.99M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$959K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$834K
4
Two Sigma Investments
Two Sigma Investments
New York
+$382K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$268K

Top Sellers

1
Ameriprise
Ameriprise
Minnesota
-$6.72M
2
JP Morgan Chase
JP Morgan Chase
New York
-$6.06M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$5.92M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.8M
5
Morgan Stanley
Morgan Stanley
New York
-$5.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
VPIM
51
Vanguard Personalized Indexing Management
California
$9.96K +$4.11K +138 +16%
TSS
52
Two Sigma Securities
New York
$9.92K -$83.6K -2,811 -74%
LBA
53
Letko, Brosseau & Associates
Quebec, Canada
$9.17K – – –
CFM
54
Catalyst Funds Management
Australia
$8.53K – – –
PAS
55
Point72 Asia (Singapore)
Singapore
$8.07K -$110K -3,682 -82%
Simplex Trading
56
Simplex Trading
Illinois
$8K -$125K -4,213 -83%
Goldman Sachs
57
Goldman Sachs
New York
$7.45K -$1.32M -44,484 -98%
BC
58
Birchview Capital
Vermont
$6.77K – – –
Russell Investments Group
59
Russell Investments Group
United Kingdom
$6.43K -$73.3K -2,463 -80%
TRCT
60
Tower Research Capital (TRC)
New York
$5.77K -$34.3K -1,152 -67%
US Bancorp
61
US Bancorp
Minnesota
$3.55K +$10.3K +346 +11,533%
UBS Group
62
UBS Group
Switzerland
$2.48K +$4.85K +163 +201%
SIA
63
Sit Investment Associates
Minnesota
$2K – – –
Citadel Advisors
64
Citadel Advisors
Florida
$1.98K -$576K -19,372 -99%
Osaic Holdings
65
Osaic Holdings
Arizona
$1.44K -$1.31K -44 -24%
Federated Hermes
66
Federated Hermes
Pennsylvania
$1.26K -$325K -10,916 -99%
Kayne Anderson Rudnick Investment Management
67
Kayne Anderson Rudnick Investment Management
California
$677 – – –
HI
68
Hoey Investments
Pennsylvania
$539 – – –
ATC
69
Adirondack Trust Company
New York
$187 – – –
Citigroup
70
Citigroup
New York
$152 -$41.8K -1,405 -99%
Barclays
71
Barclays
United Kingdom
$43 – – –
PNC Financial Services Group
72
PNC Financial Services Group
Pennsylvania
$29 -$4.76K -160 -98%
IA
73
IFP Advisors
Florida
$23 – – –
RA
74
Rise Advisors
New York
$17 – – –
MTIC
75
Missouri Trust & Investment Company
Missouri
$16 – – –
1 2
3
4 5

OM Hedge Fund Activity: Q3 2024 in Review

78 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2024, worth a combined $17.6M — down 91% from $187M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of OM and 6 opened new positions — a net loss of 44 holders — while 36 trimmed existing stakes and 16 added.

The largest buyer was GSA Capital Partners, adding an estimated $1.99M. The largest seller was Ameriprise, cutting an estimated $6.72M.

  • 78 institutional investors held Outset Medical (OM) as of Q3 2024, down from 122 in Q2 2024.
  • Funds reported $17.6M of Outset Medical stock for Q3 2024, down 91% quarter-over-quarter.
  • 6 funds opened new Outset Medical positions in Q3 2024 and 50 closed out, a net change of -44 holders.
  • The largest Outset Medical buyer in Q3 2024 was GSA Capital Partners, an estimated $1.99M added.
  • The largest Outset Medical seller in Q3 2024 was Ameriprise, an estimated $6.72M sold.

Based on aggregated 13F filings for Q3 2024.